Skip to main content
. 2023 Apr 17;11(4):e006334. doi: 10.1136/jitc-2022-006334

Figure 2.

Figure 2

Potential neoantigen profiles of 14 patients with HCC. (A) Schematic of the approach for screening potential neoantigens using computer algorithms. (B) Potential HCC neoantigen profiles determined by different indexes and HLA LOH. (C) Correlation analysis between the number of potential neoantigens and the TMB. (D) Correlation analysis between the number of potential neoantigens with different indexes and the TMB. HCC, hepatocellular carcinoma; HLA, human leukocyte antigen; LOH, loss of heterozygosity; TMB, tumor mutation burden.